These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32355541)

  • 21. Recovery of miR-139-5p in Ovarian Cancer Reverses Cisplatin Resistance by Targeting C-Jun.
    Jiang Y; Jiang J; Jia H; Qiao Z; Zhang J
    Cell Physiol Biochem; 2018; 51(1):129-141. PubMed ID: 30439707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SREBP2 contributes to cisplatin resistance in ovarian cancer cells.
    Zheng L; Li L; Lu Y; Jiang F; Yang XA
    Exp Biol Med (Maywood); 2018 Apr; 243(7):655-662. PubMed ID: 29466876
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differentially expressed genes associated with cisplatin resistance in human ovarian adenocarcinoma cell line A2780.
    Solár P; Sytkowski AJ
    Cancer Lett; 2011 Oct; 309(1):11-8. PubMed ID: 21676537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis B X-interacting protein promotes cisplatin resistance and regulates CD147 via Sp1 in ovarian cancer.
    Zou W; Ma X; Yang H; Hua W; Chen B; Cai G
    Exp Biol Med (Maywood); 2017 Mar; 242(5):497-504. PubMed ID: 28056551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cisplatin induces cell cycle arrest and senescence via upregulating P53 and P21 expression in HepG2 cells.
    Qu K; Lin T; Wei J; Meng F; Wang Z; Huang Z; Wan Y; Song S; Liu S; Chang H; Dong Y; Liu C
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Sep; 33(9):1253-9. PubMed ID: 24067199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lectin array and glycogene expression analyses of ovarian cancer cell line A2780 and its cisplatin-resistant derivate cell line A2780-cp.
    Zhao R; Qin W; Qin R; Han J; Li C; Wang Y; Xu C
    Clin Proteomics; 2017; 14():20. PubMed ID: 28546799
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-133b targets glutathione S-transferase π expression to increase ovarian cancer cell sensitivity to chemotherapy drugs.
    Chen S; Jiao JW; Sun KX; Zong ZH; Zhao Y
    Drug Des Devel Ther; 2015; 9():5225-35. PubMed ID: 26396496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BRCA1 Expression is an Important Biomarker for Chemosensitivity: Suppression of BRCA1 Increases the Apoptosis via Up-regulation of p53 and p21 During Cisplatin Treatment in Ovarian Cancer Cells.
    Horiuchi A; Wang C; Kikuchi N; Osada R; Nikaido T; Konishi I
    Biomark Insights; 2007 Mar; 1():49-59. PubMed ID: 19690636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trichostatin A up-regulates p73 and induces Bax-dependent apoptosis in cisplatin-resistant ovarian cancer cells.
    Muscolini M; Cianfrocca R; Sajeva A; Mozzetti S; Ferrandina G; Costanzo A; Tuosto L
    Mol Cancer Ther; 2008 Jun; 7(6):1410-9. PubMed ID: 18566213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of resistance to a trinuclear platinum complex in ovarian carcinoma cells.
    Perego P; Gatti L; Righetti SC; Beretta GL; Carenini N; Corna E; Dal Bo L; Tinelli S; Colangelo D; Leone R; Apostoli P; Lombardi L; Beggiolin G; Piazzoni L; Zunino F
    Int J Cancer; 2003 Jul; 105(5):617-24. PubMed ID: 12740909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long noncoding RNA ZEB1-AS1 affects paclitaxel and cisplatin resistance by regulating MMP19 in epithelial ovarian cancer cells.
    Dai C; Xu P; Liu S; Xu S; Xu J; Fu Z; Cao J; Lv M; Zhou J; Liu G; Zhang H; Jia X
    Arch Gynecol Obstet; 2021 May; 303(5):1271-1281. PubMed ID: 33151424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sustained suppression of Fas ligand expression in cisplatin-resistant human ovarian surface epithelial cancer cells.
    Schneiderman D; Kim JM; Senterman M; Tsang BK
    Apoptosis; 1999 Aug; 4(4):271-81. PubMed ID: 14692397
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanistic Nanotherapeutic Approach Based on siRNA-Mediated DJ-1 Protein Suppression for Platinum-Resistant Ovarian Cancer.
    Schumann C; Chan S; Khalimonchuk O; Khal S; Moskal V; Shah V; Alani AW; Taratula O; Taratula O
    Mol Pharm; 2016 Jun; 13(6):2070-83. PubMed ID: 27170529
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Proteomic analysis of human ovarian cancer cell lines and their platinum-resistant clones].
    Yan XD; Pan LY
    Zhonghua Fu Chan Ke Za Zhi; 2006 Sep; 41(9):584-7. PubMed ID: 17181965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TR3 modulates platinum resistance in ovarian cancer.
    Wilson AJ; Liu AY; Roland J; Adebayo OB; Fletcher SA; Slaughter JC; Saskowski J; Crispens MA; Jones HW; James S; Fadare O; Khabele D
    Cancer Res; 2013 Aug; 73(15):4758-69. PubMed ID: 23720056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of LC3-dependent protective autophagy in ovarian cancer cells by protein phosphatase 2A.
    Yin X; Zhang N; Di W
    Int J Gynecol Cancer; 2013 May; 23(4):630-41. PubMed ID: 23518861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platinum sensitivity of ovarian cancer cells does not influence their ability to induce M2-type macrophage polarization.
    Mlynska A; Povilaityte E; Zemleckaite I; Zilionyte K; Strioga M; Krasko J; Dobrovolskiene N; Peng MW; Intaite B; Pasukoniene V
    Am J Reprod Immunol; 2018 Sep; 80(3):e12996. PubMed ID: 29904979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nucleus accumbens-1/GADD45GIP1 axis mediates cisplatin resistance through cellular senescence in ovarian cancer.
    Nakayama K; Rahman M; Rahman MT; Nakamura K; Sato E; Katagiri H; Ishibashi T; Ishikawa M; Iida K; Razia S; Ishikawa N; Kyo S
    Oncol Lett; 2017 Jun; 13(6):4713-4719. PubMed ID: 28599472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overexpression of long non-coding RNA PVT1 in ovarian cancer cells promotes cisplatin resistance by regulating apoptotic pathways.
    Liu E; Liu Z; Zhou Y; Mi R; Wang D
    Int J Clin Exp Med; 2015; 8(11):20565-72. PubMed ID: 26884974
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional Activation of Mutant p53 by Platinum Analogues in Cisplatin-Resistant Cells Is Dependent on Phosphorylation.
    Xie X; He G; Siddik ZH
    Mol Cancer Res; 2017 Mar; 15(3):328-339. PubMed ID: 28031409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.